Author:
Janes Amy C.,Pizzagalli Diego A.,Richardt Sarah,Frederick Blaise deB.,Chuzi Sarah,Pachas Gladys,Culhane Melissa A.,Holmes Avram J.,Fava Maurizio,Evins A. Eden,Kaufman Marc J.
Funder
National Institute on Drug Abuse
Counter-Drug Technology Assessment Center
GlaxoSmithKline
GlaxoSmithKline and ANT North America, Inc.
Abbott Laboratories
Alkermes
Aspect Medical Systems
AstraZeneca
Bio Research
BrainCells, Inc.
Bristol-Myers Squibb Company
Cephalon
Clinical Trial Solutions
Eli Lilly and Company
Forest Pharmaceuticals, Inc.
Ganeden
J and J Pharmaceuticals
Lichtwer Pharma
GmbH
Lorex Pharmaceuticals
National Alliance for Research on Schizophrenia and Depression
National Center for Complementary and Alternative Medicine
National Institute of Mental Health
Novartis
Organon, Inc.
PamLab
LLC
Pfizer, Inc.
Pharmavite
Roche
Sanofi-Aventis
Shire, Solvay Pharmaceuticals, Inc.
Synthelabo
Wyeth-Ayerst Laboratories
Reference54 articles.
1. Implementing the Agency for Health Care Policy and Research smoking cessation guidelines: A call to action;Tingen;Clin Excell Nurse Pract,1999
2. Nicotine receptor partial agonists for smoking cessation;Cahill;Cochrane Database Syst Rev,2008
3. Antidepressants for smoking cessation;Hughes;Cochrane Database Syst Rev,2007
4. Nicotine replacement therapy for smoking cessation;Stead;Cochrane Database Syst Rev,2008
5. Nicotine replacement therapy for long-term smoking cessation: A meta-analysis;Etter;Tob Control,2006
Cited by
359 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献